Angela Vitrano

Palermo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Quantifying Morbidity Risk Attributed to Red-Cell Transfusion Volume in Optimally Transfused Patients With β-Thalassemia.

Quantifying Morbidity Risk Attributed to Red-Cell Transfusion Volume in Optimally Transfused Patients With β-Thalassemia.

Journal: American journal of hematology

Published: August 15, 2025

Lifetime Risk of Liver Disease in Patients With β-Thalassemia: Data From the de-LIGHT Retrospective Cohort Study.

Lifetime Risk of Liver Disease in Patients With β-Thalassemia: Data From the de-LIGHT Retrospective Cohort Study.

Journal: European journal of haematology

Published: April 26, 2025

Impact of lifetime anaemia and iron control on outcomes in β-thalassaemia: Data from the longitudinal de-LIGHT study.

Impact of lifetime anaemia and iron control on outcomes in β-thalassaemia: Data from the longitudinal de-LIGHT study.

Journal: British journal of haematology

Published: March 13, 2025

RP1 Dominant p.Ser740* Pathogenic Variant in 20 Knowingly Unrelated Families Affected by Rod-Cone Dystrophy: Potential Founder Effect in Western Sicily.

RP1 Dominant p.Ser740* Pathogenic Variant in 20 Knowingly Unrelated Families Affected by Rod-Cone Dystrophy: Potential Founder Effect in Western Sicily.

Journal: Medicina (Kaunas, Lithuania)

Published: December 13, 2023

Development of a Thalassemia International Prognostic Scoring System (TIPSS).

Development of a Thalassemia International Prognostic Scoring System (TIPSS).

Journal: Blood cells, molecules & diseases

Published: October 13, 2022

Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemia.

Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemia.

Journal: American journal of hematology

Published: November 02, 2021

Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia.

Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia.

Journal: British journal of haematology

Published: August 20, 2021

Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia

Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia

Journal: Haematologica

Published: March 01, 2021

A complication risk score to evaluate clinical severity of thalassaemia syndromes.

A complication risk score to evaluate clinical severity of thalassaemia syndromes.

Journal: British journal of haematology

Published: June 01, 2020

Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial.

Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial.

Journal: The Lancet. Haematology

Published: January 23, 2020

Long-term sequential deferiprone and deferasirox therapy in transfusion-dependent thalassaemia patients: a prospective clinical trial.

Long-term sequential deferiprone and deferasirox therapy in transfusion-dependent thalassaemia patients: a prospective clinical trial.

Journal: British journal of haematology

Published: July 26, 2019

Left Ventricular Diastolic Dysfunction in β-Thalassemia Major with Heart Failure.

Left Ventricular Diastolic Dysfunction in β-Thalassemia Major with Heart Failure.

Journal: Hemoglobin

Published: April 11, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026